Allergies News and Research

Latest Allergies News and Research

New molecular diagnostic test precisely identifies insect venom allergy

Bees, wasps and bumble bees pose a real health threat to individuals with venom allergy. One sting from these insects may cause potentially life-threatening anaphylactic reactions in people with these conditions.

14 Jun 2011

Cinryze data on hereditary angioedema presented at EAACI 2011

ViroPharma Incorporated today announced that data relating to Cinryze from nine accepted abstracts were presented as poster presentations at the 30th Congress of the European Academy of Allergy and Clinical Immunology (EAACI), June 11 through 15, in Istanbul, Turkey.

14 Jun 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Cypress Pharmaceutical announced today that the Food and Drug Administration (FDA) approved a new drug application (NDA) for ZUTRIPRO Oral Solution (CIII) and REZIRA Oral Solution.

14 Jun 2011

Circassia announces ToleroMune vaccine phase II trial results against cat allergy

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical trial showing that patients who received four doses of its ToleroMune cat allergy vaccine over a 12-week period maintained a statistically significant reduction in symptoms one year later.

13 Jun 2011

Study finds no link between early exposure to pets and children's risk of allergies

A new study published in the journal Clinical & Experimental Allergy reveals that keeping a dog or cat in the home does not increase children's risk of becoming allergic to the pets.

13 Jun 2011

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Biota Holdings Limited advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile).

10 Jun 2011

NIH awards $1.9M grant to Scripps Research scientist for malaria study

A scientist from The Scripps Research Institute has won a four-year, $1.9 million grant from the National Institutes of Health to better understand the parasite that causes malaria, laying the groundwork to develop better drugs to combat the widespread and deadly disease.

10 Jun 2011

Media examine HIV/AIDS epidemic as U.N. meeting prepares to convene

This week, political leaders will gather in New York at the U.N. High Level Meeting on AIDS to "frame the ongoing fight against HIV/AIDS," Nature News reports. The article includes a Q&A with Anthony Fauci, head of the NIH National Institute of Allergy and Infectious Diseases, who "explains what scientists hope the U.N. meeting will achieve".

9 Jun 2011

ACAAI issues updated guidelines for treating stinging insect hypersensitivity

Spring and summer bring bees, wasps, hornets and yellow jackets and, this year, updated advice for those who are allergic to these pesky stinging insects. More than half a million people go to emergency rooms and at least 50 die each year from insect stings.

9 Jun 2011

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States sclerotherapy market will experience rapid procedural growth stemming from favorable patient demographics and increased patient demand. Polidocanol, a sclerosing agent used to chemically treat varicose and spider veins, received FDA approval in 2010 and is expected to show significant growth in the US.

8 Jun 2011

Guardian Air REME+ system helps reduce germs, allergens and airborne toxins

Hospitals, nursery schools, and other high-traffic indoor spaces have been acting as quiet proving grounds for an advanced new form of air purification. These are normally the kinds of places where germs, allergens and airborne toxins flourish. That's soon going to be a thing of the past.

7 Jun 2011

FDA accepts Sunovion ciclesonide HFA nasal aerosol NDA for review

Sunovion Pharmaceuticals Inc. today announced that the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation has been accepted by the U.S. Food and Drug Administration.

6 Jun 2011

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced efficacy and safety data from the BRIM3 trial, a large, randomized, multi-center Phase 3 clinical study of vemurafenib in patients with previously untreated metastatic melanoma with the BRAFV600 mutation.

6 Jun 2011

Scientists demonstrate why B cells exposed to chronic HIV shut down, how they can be reactivated

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can be reactivated.

4 Jun 2011

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Female blood-feeding mosquitoes, some species of which can transmit deadly diseases such as malaria and dengue to humans, largely find their human blood meals by detecting carbon dioxide emitted when people exhale.

2 Jun 2011

Exposure to phthalates can cause children's allergy and asthma

Recent controversy over the discovery of clouding agents containing the banned chemical DEHP in beverages has caused public concerns.

2 Jun 2011

NIH scientists discuss expanded HIV testing and new prevention tools

In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease.

1 Jun 2011

Moisturisers, hair dyes cause serious adverse effects

Permanent hair dye gives the most serious adverse effects, yet there are also many reactions to facial and body moisturisers. This comes from the first report from the National Register of Adverse Effects from Cosmetic Products published by the Norwegian Institute of Public Health.

31 May 2011

Study suggests new therapeutic targets for virally-induced asthma attacks

When children with asthma get the flu, they often land in the hospital gasping for air. Researchers at Children's Hospital Boston have found a previously unknown biological pathway explaining why influenza induces asthma attacks.

30 May 2011

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

30 May 2011

Allergies News and Research

Latest Allergies News and Research

New molecular diagnostic test precisely identifies insect venom allergy

Cinryze data on hereditary angioedema presented at EAACI 2011

Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold

Circassia announces ToleroMune vaccine phase II trial results against cat allergy

Study finds no link between early exposure to pets and children's risk of allergies

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

NIH awards $1.9M grant to Scripps Research scientist for malaria study

Media examine HIV/AIDS epidemic as U.N. meeting prepares to convene

ACAAI issues updated guidelines for treating stinging insect hypersensitivity

Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market

Guardian Air REME+ system helps reduce germs, allergens and airborne toxins

FDA accepts Sunovion ciclesonide HFA nasal aerosol NDA for review

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

Scientists demonstrate why B cells exposed to chronic HIV shut down, how they can be reactivated

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Exposure to phthalates can cause children's allergy and asthma

NIH scientists discuss expanded HIV testing and new prevention tools

Moisturisers, hair dyes cause serious adverse effects

Study suggests new therapeutic targets for virally-induced asthma attacks

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Allergies News and Research

Latest Allergies News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in